[{"Assets_0_Q2_USD":27786656.0,"CommonStockSharesOutstanding_0_Q2_shares":25740458.0,"EarningsPerShareBasic_1_Q2_USD":-0.33,"EarningsPerShareBasic_2_Q2_USD":-1.04,"EarningsPerShareDiluted_1_Q2_USD":-0.34,"EarningsPerShareDiluted_2_Q2_USD":-1.05,"NetIncomeLoss_1_Q2_USD":-7539879.0,"NetIncomeLoss_2_Q2_USD":-9460380.0,"StockholdersEquity_0_Q2_USD":-33565089.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":25733467.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":25364247.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":25733467.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":25364247.0,"Ticker":"OTLK","CIK":"1649989","name":"ONCOBIOLOGICS, INC.","OfficialName":"Outlook Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"403697299.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180515"}]